NEW YORK--(BUSINESS WIRE)--OMRIX Biopharmaceuticals, Inc. (“OMRIX” or the “Company”) (NASDAQ: OMRI), a commercial-stage biopharmaceutical company that develops and markets biosurgical and antibody-based products, announced today that Robert Taub, President and Chief Executive Officer, is scheduled to give a company presentation at the CIBC World Markets 17th Annual Healthcare Conference on Tuesday, November 7, 2006 at 1:15 pm ET at the Waldorf-Astoria Hotel in New York City.
